Abstract | OBJECTIVE: To describe the clinical presentation and treatment of the combined syndrome of fasciitis and morphea in children. SETTING: PATIENTS: Six children who were referred for signs or symptoms of fasciitis were observed. SELECTION PROCEDURES: All children who were referred for fasciitis were included in the study. INTERVENTIONS: MEASUREMENTS AND RESULTS: Symptoms of morphea appeared 1 year before to 4 years after the first signs of fasciitis were observed. The fasciitis was characterized by usually symmetrical, centrifugal swelling, pain, and contracture formation. The morphea and fasciitis did not appear in the same areas of the body. CONCLUSIONS:
|
Authors | J J Miller 3rd |
Journal | American journal of diseases of children (1960)
(Am J Dis Child)
Vol. 146
Issue 6
Pg. 733-6
(Jun 1992)
ISSN: 0002-922X [Print] United States |
PMID | 1595630
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Antinuclear
- Fructose-Bisphosphate Aldolase
- Penicillamine
- Prednisone
|
Topics |
- Adolescent
- Antibodies, Antinuclear
(blood)
- Biopsy
- Blood Sedimentation
- Child
- Child, Preschool
- Eosinophilia
(complications, diagnosis, drug therapy)
- Eosinophils
(chemistry)
- Fasciitis
(complications, diagnosis, drug therapy)
- Female
- Fructose-Bisphosphate Aldolase
(blood)
- Humans
- Male
- Penicillamine
(administration & dosage, therapeutic use)
- Prednisone
(administration & dosage, therapeutic use)
- Range of Motion, Articular
- Scleroderma, Localized
(complications, diagnosis, drug therapy)
|